Ataxia-telangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility. (Q39187764)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 April 2013

Language	Label	Description	Also known as
English	Ataxia-telangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility.	scientific article published on 26 April 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23445485%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Ataxia-telangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23445485%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

based on heuristic

inferred from title

Akiyoshi Takami

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23445485%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

J Luis Espinoza

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23445485%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Ly Q Trung

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23445485%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Shinji Nakao

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23445485%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

26 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23445485%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23445485%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

104

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23445485%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23445485%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

657-662

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23445485%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

The NKG2D receptor: immunobiology and clinical implications.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Promiscuity and the single receptor: NKG2D.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Therapeutic potential of resveratrol: the in vivo evidence

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Resveratrol and cellular mechanisms of cancer prevention

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR-p53- and -Nbs1-dependent manner

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Hydroxyurea upregulates NKG2D ligand expression in myeloid leukemia cells synergistically with valproic acid and potentially enhances susceptibility of leukemic cells to natural killer cell-mediated cytolysis

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Anti-moesin antibodies derived from patients with aplastic anemia stimulate monocytic cells to secrete TNF-alpha through an ERK1/2-dependent pathway.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Cell cycle checkpoint signaling through the ATM and ATR kinases

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

ATM protein kinase: the linchpin of cellular defenses to stress

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Cancer chemopreventive activity of resveratrol.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Chemoprevention in experimental animals

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Thermal- and Oxidative Stress Causes Enhanced Release of NKG2D Ligand-Bearing Immunosuppressive Exosomes in Leukemia/Lymphoma T and B Cells

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Soluble NKG2D ligands: prevalence, release, and functional impact.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Modulation of Akt and ERK1/2 pathways by resveratrol in chronic myelogenous leukemia (CML) cells results in the downregulation of Hsp70

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation.

1 reference

https://api.crossref.org/works/10.1111%2FCAS.12141

21 January 2018

Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23445485

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/23445485

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging

1 reference

https://pubmed.ncbi.nlm.nih.gov/23445485

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/CAS.12141

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23445485%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

release_eldtfetqcfanrjpbtdlnsgj6la

1 reference

https://api.fatcat.wiki/v0/release/eldtfetqcfanrjpbtdlnsgj6la

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23445485%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39187764&oldid=1836218796"